MONAS
FINANCIAL
Home
About
Research
Data
Pricing
Team
News
Analysis
Press
Contact
Legal
← News
Morgan Stanley Maintains Equal-Weight on Amgen, Raises Price Target to $410
Analyst Ratings
AMGN
Nov 4
AI-curated analysis for informational purposes only — not investment advice.
Morgan Stanley Maintains Equal-Weight on Amgen, Raises Price Target to $410
Read the full story at benzinga.com →